Director, External Corporate Communications

NWRPros is partnering with a clinical‑stage biotechnology company to fill a key leadership role in Vancouver, Canada. The organization focuses on locally delivered, extended‑release therapies that have the potential to tackle high‑need therapeutic areas. They’re seeking a Director of External Corporate Communications to shape the company’s external narrative as it advances a development program with a Phase 2/3 product. This is a full‑time, on‑site position that will suit someone who enjoys translating complex science into clear, non‑promotional messaging for investors, clinicians and other external audiences.

The person in this role will own the external communications strategy and ensure the evolving story is told consistently across channels. They’ll work closely with the executive team and multiple functional partners, including commercial, investor relations, clinical and medical affairs, and human resources, to steward the corporate brand and drive messaging that supports growth and stakeholder understanding. A central part of the job is creating and refining the overarching narrative and message architecture, then guiding its deployment across the website, investor materials, social channels, conferences and other external touchpoints, with subject‑matter support as needed.

It’s a good fit for a communications professional who thrives in a regulated biotech or pharma environment, can influence senior leaders, and enjoys cross‑functional collaboration to bring a strategic story to life across media, investor forums and scientific gatherings.

Steering the external voice across channels

Day to day, you’ll shape and implement messaging that clearly conveys corporate and product narratives to the outside world, balancing accuracy with reach. You’ll partner with the executive team and other stakeholders to maintain a cohesive brand voice and ensure content alignment across the site, investor decks, social channels and medical communications. You’ll own the process of updating the company’s narrative and message architecture so external materials stay consistent as the science and milestones evolve, coordinating approvals with key leaders along the way.

Content creation will be a core focus, including drafting external materials such as website copy, press releases, R&D day materials and investor communications. You’ll collaborate with clinical and medical experts to ensure scientific content remains accurate, non‑promotional and appropriate for external audiences, with the CMO or other designated medical leads providing the final review for scientific elements.

In the investor relations and public relations arena, you’ll contribute to press releases and corporate updates, and help prepare materials for earnings calls, conference presentations and the annual report. You’ll craft talking points and Q&A for investors, media and public forums to keep messaging disciplined, and support positioning of IR materials, ensuring consistency and compliance across touchpoints. You’ll also help coordinate an external communications calendar around clinical catalysts, aligning with disclosure obligations and the company’s disclosure committee. Finally, you’ll manage the company’s LinkedIn and X/Twitter presence with a voice that fits a regulated public company.

Must-have ingredients and nice-to-haves

Here’s what the client is looking for, rephrased from the original requirements:

• A bachelor’s degree in life sciences or a related field, with additional qualifications in communications or journalism considered a plus
• About eight to ten years of progressively senior communications, investor relations or public relations experience, including at least five years in biotech, pharma or life sciences
• A solid understanding of the healthcare ecosystem, including clinical workflows, regulatory landscapes, reimbursement contexts, and therapeutic areas such as GI, immunology or specialty therapeutics
• Strong writing and editing skills with the ability to turn clinical or scientific data into clear, accurate, non‑promotional external messaging
• Experience developing and executing comprehensive communication strategies and tactics
• Proven track record in public‑company investor relations and financial communications, including press releases, disclosure coordination and earnings materials
• Working knowledge of Canadian and/or U.S. securities disclosure requirements and familiarity with a disclosure committee
• Relationship management skills with analysts and agency partners, plus sound judgement under time pressure and in sensitive situations
• Ability to influence senior leadership in a fast‑moving, entrepreneurial, highly regulated environment and to collaborate well with others
• Excellent planning and organizational skills with the ability to multi‑task
• Willingness and ability to travel domestically and internationally
• Proficiency with Microsoft Word, Excel, SharePoint and PowerPoint

• Highly motivated self‑starter who identifies opportunities to improve operations
• Clear communicator capable of presenting to senior management and external stakeholders
• Proactive problem‑solver who can troubleshoot equipment issues and safety concerns independently
• Strong organizational and time management skills to juggle multiple priorities
• A commitment to staying current with developments in GI disease and EoE as the company’s strategic focus areas

Compensation and practical details

The role is on‑site in Vancouver, Canada, and is offered as a full‑time position. The base compensation ranges from 165,000.00 CAD to 210,000.00 CAD annually, with incentive compensation based on performance and contract terms. A competitive benefits package is included. The job description notes the possibility of domestic and international travel as part of the role.

In addition, the company highlights that the compensation package may include incentive components tied to performance and negotiated terms, alongside a comprehensive benefits program.

Tips for candidates

Lead with your biotech and development‑stage program experience on the top of your resume. Highlight eight to ten years of senior communications work, making sure to call out at least five years in biotech, pharma or life sciences, and your experience supporting Phase 2/3 programs rather than early‑stage work alone.

Show concrete proof you can translate clinical data into external messages. Include examples (or a portfolio can be discussed in interviews) of non‑promotional materials you’ve drafted, such as press releases, investor decks or website copy, and describe how you collaborated with a CMO or clinical leadership to validate scientific content.

Be ready to discuss governance and regulatory processes. Expect to talk about how you’ve worked with disclosure committees, coordinated external messaging with regulatory requirements and ensured consistency across all investor and public communications.

Ask a thoughtful question about the company’s external communications trajectory. For example, you could inquire how they balance rigorous scientific accuracy with investor messaging, and how the disclosure committee influences day‑to‑day communications planning during a Phase 2/3 program.